26 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
18 Apr 22
Additional proxy soliciting materials
7:36am
Acquisitions of preclinical compounds AUR200 and AUR300 bolster innovation pipeline Strong balance sheet to fund current initiatives and FDA-related post
DEF 14A
3c2pke7jiu0n1lsh
10 May 21
Definitive proxy
4:06pm
PRE 14A
c5fu1mks
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-99.1
nqi6ovq7jun
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
nlc4 0iez
24 Feb 21
Annual report
4:09pm
6-K
EX-99.1
cwavmxg4zxmp
16 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
vv6z94s7
29 Oct 20
Aurinia Pharmaceuticals Inc. 6-K
9:00am
6-K
EX-99.3
kh789gvd5n88vijan
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
6-K
EX-99.1
h1ay65 i9k81jg
17 Mar 20
Aurinia Pharmaceuticals Inc. 6-K
5:05pm
40-F
EX-99.1
gt9zha ebb
5 Mar 20
Annual report (Canada)
4:06pm
6-K
EX-99.2
5syvn
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
40-F
EX-99.1
ka6seqfvtlk6ex l7
19 Mar 19
Annual report (Canada)
4:16pm
6-K/A
EX-99.3
he4 ev9n6kt1a0r0ht
17 May 18
Current report (foreign) (amended)
12:00am